Technical Analysis for ACHV - Achieve Life Sciences, Inc.

Grade Last Price % Change Price Change
grade F 1.33 2.31% 0.03
ACHV closed up 2.31 percent on Friday, January 18, 2019, on 36 percent of normal volume.
4 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical ACHV trend table...

Date Alert Name Type % Chg
Jan 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Jan 18 20 DMA Support Bullish 0.00%
Jan 18 Calm After Storm Range Contraction 0.00%
Jan 18 Inside Day Range Contraction 0.00%
Jan 18 BB Squeeze Ended Range Expansion 0.00%
Jan 17 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.31%
Jan 17 Crossed Above 20 DMA Bullish 2.31%
Jan 17 Bollinger Band Squeeze Range Contraction 2.31%
Jan 17 Calm After Storm Range Contraction 2.31%
Jan 17 Inside Day Range Contraction 2.31%

Older signals for ACHV ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:

Profile
Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.
Is ACHV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jan 16 Biocept leads healthcare gainers; Achieve Life Sciences and Revance Therapeutics among losers
Jan 15 Microbot Medical and CHF Solutions among healthcare gainers; Stellar Biotechnologies and Biocept among losers
Jan 15 SSYS, ARRY among premarket gainers
Dec 28 5 Top Rising P/E Stocks to Enjoy Solid Gains
Dec 26 EyePoint Pharmaceuticals and Sesen Bio among healthcare gainers; ZIOPHARM Oncology and Agenus among losers
Dec 19 The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas
Dec 18 Achieve Announces Update on Cytisinicline Clinical Development Program
Dec 13 The Daily Biotech Pulse: Vivus Extends Supply Deal With Sandoz, Applied Genetic Snaps Ties With Biogen
Dec 6 The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering
Nov 29 Zacks.com highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis Pharmaceuticals
See more ACHV news...
Indicators
Indicator Value
52 Week High 32.0
52 Week Low 1.045
Average Volume 121,364
200-Day Moving Average 4.7461
50-Day Moving Average 1.4974
20-Day Moving Average 1.2715
10-Day Moving Average 1.296
Average True Range 0.1531
ADX 15.99
+DI 14.089
-DI 15.7276
Chandelier Exit (Long, 3 ATRs ) 1.1107
Chandelier Exit (Short, 3 ATRs ) 1.5043
Upper Bollinger Band 1.4025
Lower Bollinger Band 1.1405
Percent B (%b) 0.72
BandWidth 20.605584
MACD Line -0.053
MACD Signal Line -0.0783
MACD Histogram 0.0252
Fundamentals Value
Market Cap 14.56 Million
Num Shares 10.9 Million
EPS -56.38
Price-to-Earnings (P/E) Ratio -0.02
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.47
Resistance 3 (R3) 1.45 1.40 1.44
Resistance 2 (R2) 1.40 1.36 1.40 1.43
Resistance 1 (R1) 1.36 1.34 1.38 1.38 1.43
Pivot Point 1.31 1.31 1.32 1.31 1.31
Support 1 (S1) 1.27 1.27 1.29 1.29 1.23
Support 2 (S2) 1.22 1.25 1.22 1.23
Support 3 (S3) 1.18 1.22 1.22
Support 4 (S4) 1.20